Siga Technologies (SIGA) Net Income towards Common Stockholders (2010 - 2025)

Siga Technologies (SIGA) reported Net Income towards Common Stockholders of -$6.4 million for Q3 2025, down 573.67% on a YoY basis from $1.3 million in Q3 2024, and down 117.95% quarter-over-quarter from $35.5 million in Q2 2025.

Siga Technologies (SIGA) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends

Siga Technologies has reported Net Income towards Common Stockholders for 16 years, with the latest figure at -$6.4 million in Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders fell 573.67% year-over-year to -$6.4 million; the trailing twelve-month figure through Dec 2025 stood at $28.7 million (down 51.48% YoY), and the FY2024 full-year result was $59.2 million, down 13.01% from the prior year.
  • Net Income towards Common Stockholders for Q3 2025 stood at -$6.4 million, down from $35.5 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $73.4 million in Q4 2021, with the low at -$6.4 million in Q3 2025.
  • Historically, Net Income towards Common Stockholders has averaged $13.6 million across 5 years, with a median of -$258928.0 in 2021.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 9000.73% — and 2025, when it sank 573.67%.
  • Siga Technologies' Net Income towards Common Stockholders stood at $73.4 million in 2021, then tumbled by 101.11% to -$811794.0 in 2022, then surged by 9000.73% to $72.3 million in 2023, then sank by 36.67% to $45.8 million in 2024, then sank by 113.91% to -$6.4 million in 2025.
  • The last three Net Income towards Common Stockholders figures came in at -$6.4 million (Q3 2025), $35.5 million (Q2 2025), and -$370415.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 366.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Siga Technologies 310.79 Mn 155.83 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -6.37 Mn
Jun 30, 2025 35.47 Mn
Mar 31, 2025 -370,415.00
Dec 31, 2024 45.76 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 10.32 Mn
Dec 31, 2023 72.26 Mn
Sep 30, 2023 -393,066.00
Jun 30, 2023 -2.88 Mn
Mar 31, 2023 -918,255.00
Dec 31, 2022 -811,794.00
Sep 30, 2022 33.04 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 -364,455.00
Dec 31, 2021 73.38 Mn
Sep 30, 2021 -3.11 Mn
Jun 30, 2021 -258,928.00
Mar 31, 2021 -1.73 Mn
Dec 31, 2020 20.16 Mn